Menu

RedHill Investor and Analyst Event

Nov 22, 2019

The event featured presentations from RedHill's management team who provided an overview of the Company's U.S. commercial strategy for launching Talicia® and Aemcolo®. RedHill’s expects to launch Aemcolo® in Q4/19 and Talicia® in Q1/20 with its expanding dedicated sales force. 

For further information please contact: investors@redhillbio.com

Location:

New York